Introduction
Liposomes are flexible micro/nanoparticles consisting of lipid bilayers that can be used to encapsulate drugs or antigens (1) . Liposomal formulations have been demonstrated to increase antigen uptake by antigen-presenting cells such as dendritic cells and macrophages (2, 3) and to induce mixed T h 1/T h 2 immune responses (4) (5) (6) . Most of the liposomes described so far are composed of lipids frequently found in the cellular membrane, although cationic lipids and lipids from several bacterial species have also been included in liposomes to enhance their immunogenicity and adjuvant effects (7) (8) (9) . However, previous results from our group demonstrated that also liposomal preparations containing only lipids commonly found in human cell membranes, like phosphatidylcholine and cholesterol (Chol), stimulate potent immune responses (4, 10, 11) .
B-1 cells represent the main B-cell population of the peritoneal and pleural cavities in mice (12) and differ from conventional B lymphocytes (B-2) in surface markers, antibody repertoire, developmental pathway and BCR signaling (13) . CD5 expression splits B-1 cells into two subsets: CD5 + B-1a and CD5
− B-1b cells, which exhibit different functions in the immune system (14) (15) (16) .
The phosphatidylcholine repertoire of mouse CD5 + B-1 cells was initially identified using liposomes composed of this lipid that were recognized by surface IgM (17) . It was later demonstrated that this specificity was abundant among peritoneal B-1 cells (18) . The specific recognition of phosphatidylcholine was proven by the inability of vesicles containing phosphatidylglycerol to inhibit the interaction between B-1 cells and phosphatidylcholine liposomes (17, 18) . Also, using phosphatidylcholine liposomes it was shown that antibodies against bromelain-treated mouse red blood cells (BrMRBC) included this specificity (19, 20) . Furthermore, studies of BrMRBC-binding B cells showed the expression of CD5 (21) .
The impact of B-1 cells on the immune response induced by antigens encapsulated in phosphatidylcholine liposomes has not been studied so far. This led us to study whether B-1 cells participate in the humoral response induced against the model antigen ovalbumin (OVA) encapsulated in dipalmitoylphosphatidylcholine (DPPC):Chol liposomes (Lp DPPC/OVA) using X-linked immunodeficient (xid) mice, which are deficient in B-1 cells. In addition, we explored the role of phosphatidylcholine in the adjuvant properties of liposomes and its influence on the B-1-cell subsets. We could show that B-1 cells directly contribute to the adjuvant properties of DPPC-containing liposomes. Antigen encapsulated in these liposomes was phagocytosed more efficiently by B-1 cells than in soluble form and induced their migration from the peritoneal cavity (PerC) to the spleen. Using liposomes containing dipalmitoylphosphatidylglycerol (DPPG) as a control instead of DPPC, we showed that the presence of phosphatidylcholine in the liposomal formulation seemed to be crucial for these effects.
Methods

Reagents
OVA grade V, a model antigen used in immunization protocols in soluble form or encapsulated in liposomes, and OVA grade II used to coat ELISA plates were purchased from SigmaAldrich (St Louis, MO, USA). DPPC and Chol were purchased from Northern Lipids, and DPPG and sphingomyelin (SM) from Avanti Polar Lipids (Alabaster, AL, USA).
Mice
Female BALB/c mice, 6-8 weeks of age, were purchased from the Center for Laboratory Animal Production (Cuba) or bred at the Development Center of Experimental Models for Medicine and Biology of the UNIFESP, Brazil. Female and male BALB/xid mice were bred at the CIM (Cuba) and also at the UNIFESP. All animals were specific pathogen-free and were maintained under standard animal housing conditions with free access to water and standard rodent diet.
Ethics statement
Experiments were performed in accordance with the respective institutional guidelines. All procedures were performed in compliance with the protocols approved by the Institutional Committee for the Care and Use of Laboratory Animals of the Center of Molecular Immunology (CICUAL, 0017/2008). The animals were sacrificed by CO 2 asphyxiation.
Encapsulation of OVA in liposomes and characterization of vesicles
Liposomes encapsulating OVA were obtained by a procedure based on dehydration and rehydration of vesicles developed by Kirby and Gregoriadis (22) , which is described in Supplementary Methods, available at International Immunology Online.
B-1-cell purification
Cells were collected from the PerC of mice by repeated washing with RPMI 1640 medium (Sigma-Aldrich) and labeled with the following alternative combinations of mAbs (BD Biosciences Pharmingen, San Diego, CA, USA): FITC-conjugated antimouse CD23 (FITC-CD23) and PE-conjugated anti-mouse CD19 (PE-CD19); PE-conjugated anti-mouse CD23 (PE-CD23) and cy-chrome 5.5 (Cy5.5)-conjugated anti-mouse CD19 (PE Cy5.5-CD19); PE-CD23 and cy-chrome 7 (Cy7)-conjugated anti-mouse CD19 (PE Cy7-CD19) or PE-CD23 and allophycocyanin (APC)-conjugated anti-mouse CD19 (APC-CD19). CD23 − CD19
+ cells were sorted out using a FACSArias II flow cytometer (BD Biosciences, San Jose, CA, USA) with 98.8% purity.
Adoptive transfer of B-1 cells
Cell suspensions containing 10 6 purified B-1 cells in 200 µl of sterile PBS were injected i.p. into male BALB/xid recipients. In some experiments, cells (10 6 ) were previously labeled with 10 nM Qtracker solution (Qtracker® Cell Labeling Kits, Invitrogen, Paisley, UK) for 60 min at 37°C followed by two washes with RPMI and resuspension in PBS. For this experiment, B-1 cells were sorted out using PE-CD23 and PE Cy5.5-CD19 antibodies. Experiments were performed 1 week after B-1 cells adoptive transfer.
Immunization protocols
Mice were immunized by i.p. injection two times in a 14-day interval. The animals were bled at the start of the experiment and 7 days after the last immunization. Anti-OVA and anti-lipid antibody responses were evaluated by ELISA as described in Supplementary Methods, available at International Immunology Online. To evaluate the influence of the liposomes on B-1-cell subsets, the cells were harvested from the PerC by washing with RPMI 1640 medium 7 days after the last immunization.
Flow cytometry
For phenotypic characterization, the cell suspensions were pre-incubated with an anti-mouse CD16/CD32 mAb (BD Biosciences Pharmingen) to block Fcγ II/III receptors before staining with fluorochrome-conjugated antibodies. The cells were stained with different combinations of mAbs (BD Biosciences Pharmingen): FITC-conjugated anti-CD11b (FITC-CD11b); PE-CD19; PE cy-chrome 5 (Cy5)-conjugated anti-CD5 (PE Cy5-CD5); PE Cy5.5-CD19; PE Cy5.5-CD11b To analyze DPPC liposome-specific IgM, the cells were stimulated as above for 72 h, and the presence of liposomebinding IgM in culture supernatants was determined by flow cytometry using DPPC:Chol empty vesicles and a biotinylated goat anti-mouse IgM antibody (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) followed by PE-conjugated streptavidin (BD Biosciences Pharmingen). + cells were sorted out, washed twice and fixed with 4% paraformaldehyde in PBS, pH 7.4, for 10 min. After washing, the cells were seeded to glass slides using cytological centrifuge (Cito Spin, HistoLine Laboratories, Milan, Italy). Nuclei were stained with DAPI (Sigma-Aldrich) for 1 min at room temperature and slides were mounted in Fluoroshield™ (Sigma-Aldrich) anti-fading medium. Cells were examined by confocal microscopy using a Leica TCS SP5 CTR 6500 microscope (Leica Microsystems, Buffalo Grove, IL, USA) and the images were analyzed with the free software ImageJ 1.43u (Wayne Rasband, Washington, DC, USA).
Statistical analysis
Statistical analysis was performed using SPSS software version 16.0 (SPSS). The Kolmogorov-Smirnov test was used to verify normal distribution of the data and the Levene test to determine the homogeneity of variance. Data with normal distribution and equality of variance were analyzed with the Student's t parametric test to assess statistical significance between the means of two independent groups or one-way ANOVA simple classification when more than two groups were compared, with Tukey's post-hoc test. Data not normally distributed or without equality of variance, even after scale transformation, were analyzed using the KruskalWallis non-parametric test with Dunn's post-hoc test. In cases of pair-wise comparisons, the Mann-Whitney U-test was used.
Results
B-1 cells mediate enhanced antibody responses against OVA encapsulated in DPPC liposomes
In a dose-response study, 2 μg of OVA encapsulated in DPPC liposomes induced higher OVA-specific IgM, IgG and IgG1 titers than OVA in PBS, while for higher doses no significant differences were detected (Supplementary Figure (Fig. 1A and B) , this effect was not seen in BALB/xid mice, where the antibody response against OVA was indistinguishable from that obtained in wild-type animals immunized with PBS/OVA (Fig. 1A and B) . Sera from the BALB/c mice immunized with Lp DPPC/OVA were also evaluated against DPPC and Chol and only IgM antibodies against DPPC were found (Fig. 2) . This response was specific for the phosphocholine moiety, as no reactivity was detected against DPPG, with the same non-polar carbon structure as DPPC, while the sera recognized SM, which shares the same polar head group with DPPC. As expected, the anti-DPPC antibody titer induced in the BALB/xid mice immunized with Lp DPPC/ OVA was lower than that of the BALB/c mice injected with the same immunogen, and similar to that elicited by the antigen in PBS (Fig. 1C) .
We confirmed the crucial role of B-1 cells in the humoral response induced by Lp DPPC/OVA by reconstituting BALB/xid mice with B-1 cells from wild-type mice (BALB/xid+B-1). Successful reconstitution was verified by FACS analysis (Supplementary Figure 2 , available at International Immunology Online). In the presence of B-1 cells, OVA-specific IgG, IgG1 and IgG2a as well as DPPCspecific IgM titers induced by Lp DPPC/OVA significantly increased (Fig. 1D-G) .
To 
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International Immunology Online). To confirm this decrease, the total number of B-1 cells and their subsets in the PerC was also estimated. Immunization with Lp DPPC/OVA led to a significant reduction in only the B-1a-cell subset and consequently the total peritoneal B-1 cells in comparison with PBS/OVA (Fig. 1H-J 1. 90 ± 0.82 for B-1, B-1a and B-1b, respectively . In contrast, PBS/OVA injection did not influence this population, as equivalent numbers of B-1 cells and their subsets were detected when comparing with non-immunized mice (Fig. 1H-J) .
B-1 cells appear to efficiently incorporate OVA encapsulated in DPPC liposomes, migrate from the PerC to the spleen in immunized mice and secrete anti-phosphatidylcholine IgM
Encapsulation of FITC-OVA into liposomes significantly improved in vitro uptake by B-1 cells irrespective of the incubation time (Fig. 3) . (Fig. 4B) . In contrast, an equivalent number of FITC + cells was detected using these two labels in mice immunized with PBS/FITC-OVA at all assessed times (Fig. 4C) . However, at 18 h no significant differences were detected between the two staining strategies (Fig. 4B) . The internalization of FITC-OVA encapsulated into Lp DPPC by B-1 cells in vivo was also visualized by confocal microscopy ( Fig. 4D and E) . The B-1 cells exhibited green brilliant spots inside and near nuclei corresponding to the labeled protein.
Furthermore, we investigated whether liposome-encapsulated OVA would induce B-1 cell migration from the PerC to the spleen after i.p. immunization. The BALB/xid+labeled B-1 mice immunized with Lp DPPC/FITC-OVA and PBS/FITC-OVA showed antigen-transporting B-1 cells (Qtracker+/FITC + cells) in the spleen at 1 and 4 h, which were undetectable at 18-h post-immunization. However, the highest amount of double stained cells was seen in mice immunized with Lp DPPC/ FITC-OVA (Fig. 4F) .
Anti-liposome IgM, as surrogate of anti-phosphatidylcholine antibodies, was measured in culture supernatants of B-1 cells stimulated with Lp DPPC/OVA or PBS/OVA in order to determine if the stimulation of B-1 cells with Lp DPPC/OVA in vitro induced an increase in antibody secretion by these cells. In contrast to stimulation with PBS/OVA, the B-1 cells primed with Lp DPPC/OVA displayed a >2-fold increase in anti-liposome IgM secretion when compared with control non-primed cells (Fig. 5) .
Phosphatidylcholine seems to play a major role in the adjuvant properties of DPPC liposomes
To study the impact of liposomal phosphatidylcholine on the adjuvant properties of DPPC liposomes, we also prepared OVA encapsulated in DPPG-containing liposomes. The encapsulation efficiency of DPPG:Chol liposomes for OVA was higher (72.7%) than that previously reported for DPPC:Chol liposomes (52%) (11) . Lp DPPG/OVA exhibited a similar size compared with Lp DPPC/OVA (~1 µm), but less polydispersity. Both liposomal compositions carried negative charge, but as expected Lp DPPG/OVA showed the highest negative potential (Supplementary Table 1 , available at International Immunology Online). 
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OVA encapsulated in DPPC:Chol or DPPG:Chol liposomes induced significantly higher titers of anti-OVA IgG, IgG1 and IgG2a than PBS/OVA in BALB/c mice (Fig. 6A-C) . However, the highest antibody titers were obtained with Lp DPPC/ OVA, together with a significantly higher IgG2a/IgG1 ratio (2.74 ± 0.38) compared with Lp DPPG/OVA (1.35 ± 0.23) (P < 0.05) and PBS/OVA (0.67 ± 0.20) (P < 0.01).
Considering that Lp DPPG/OVA significantly enhanced the anti-OVA antibody response in the BALB/c mice with respect to PBS/OVA, we also evaluated the effect of this liposomal preparation in BALB/xid mice. As shown in Fig. 6A-C , Lp DPPG/OVA induced a comparable anti-OVA antibody response in terms of IgG, IgG1 and IgG2a titers in both mouse strains. In contrast, antibody levels elicited by Lp DPPC/OVA were lower in BALB/xid mice, confirming the previous experiments (Fig. 1A, B, D-G) . Except for IgG1, where no differences were observed in the BALB/xid mice, the anti-OVA antibody titers induced by the DPPC liposomes were higher than those obtained with the DPPG-based preparation in all cases (Fig. 6A-C) . In both mouse strains, lipid-specific IgM induced by Lp DPPC/OVA recognized DPPC but not DPPG, while the Lp DPPG/OVA preparation did not induce detectable anti-lipid antibodies ( Fig. 6D and E) .
Immunization with either Lp DPPG/OVA or PBS/OVA did not provoke any change in the composition of the peritoneal B-1-cell sub-populations. In contrast, Lp DPPC/OVA induced a significant decrease in the number of total B-1 and B-1a cells in the PerC (Fig. 6F-H) , as previously shown (Fig. 1H-J) . B-1 cells from BALB/c mice exhibited a significantly lower ability to uptake the labeled antigen from DPPG/FITC-OVA than from DPPC/FITC-OVA liposomes (Fig. 7) .
Discussion
Liposomes enhance antigen uptake, processing and presentation by antigen-presenting cells (23, 24) and prolong antigen presence at the injection site (23) (24) (25) . Several studies have investigated the cellular mechanisms (mainly in dendritic cells and macrophages) underlying the adjuvant properties of liposomes (2, 3) . Although B cells are also considered professional antigen-presenting cells, their influence on the immune response induced by liposomes has not been studied extensively.
In the present work, we demonstrated the immune humoral stimulatory properties of DPPC:Chol liposomes loaded with OVA. This liposomal preparation induced a T h 1/T h 2-balanced humoral response irrespective of the OVA dose, which corroborates previous results from our group with a different antigen (4). A similar response pattern has also been reported for other liposomal formulations (5, 6) . Interestingly, liposomal DPPC was able to induce IgM antibodies specific for the phosphocholine polar head, while Chol did not exhibit immunogenicity under our experimental conditions.
The adjuvant properties of DPPC liposomes were significantly reduced in the B-1-cell-deficient BALB/xid mice, indicating a role of these cells in the immune response induced by this formulation. Although BALB/xid mice display a severe reduction of the B-1-cell population, they have ~30-50% of conventional follicular B cells of normal mice (26, 27) . However, the restoration of the immunostimulatory properties of DPPC liposomes in BALB/xid mice by B-1 cells adoptive transfer demonstrated their participation in this effect. Additionally, the liposomal preparation, with or without OVA, reduced the numbers of peritoneal B-1 cells in immunized BALB/c mice, suggesting a direct effect of liposomal lipids, probably of DPPC, on this cell population. A similar reduction of peritoneal B cells has been observed after i.p. injection of bacteria or bacterial components such as lipid A and peptidoglycan (28) .
Studies of B-1-cell responses in the context of pathogen exposure or tissue injury have shown that there are at least three distinct response types (29) . In the first type of response, B-1 cells produce high levels of polyreactive IgM antibodies at the site of infection (15) . The second type occurs in response to various stimuli delivered i.p. or i.v., provoking a rapid migration of both B-1a and B-1b cells from the PerC to the spleen or mucosal tissues, where they differentiate into IgM-or IgA-secreting cells, respectively. A third outcome, attributed exclusively to the B-1b-cell subset, is the accumulation of a 'memory' B-cell population (29) . Our present results are consistent with the second type of response. DPPC liposomes provoked a decrease in peritoneal B-1 cells, with evidence for their splenic trafficking (including those loaded with antigen), more efficiently than PBS/OVA. Moreover, the high DPPC-specific IgM titers observed in the BALB/c but not the BALB/xid mice suggest the differentiation of B-1 cells into IgM-secreting cells. Anti-phosphatidylcholine B-1 cells have been shown to migrate from the PerC to the spleen and differentiate into plasma cells even without deliberate immunization (30) . Although the DPPC-specific antibody titers induced by Lp DPPC/OVA were lower in the BALB/xid animals, we cannot rule out that anti-phosphatidylcholine antibodies were produced by B-2 cells or by antigen-specific B-1 cells expanded in the BALB/xid mice after immunization. In fact, expansion of B-1b cells in xid (CBA/N) mice after infection with Borrelia hermsii has been demonstrated (31). 
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Previous work has shown the recognition of phosphatidylcholine but not of phosphatidylglycerol by B-1 cells (17, 18) . Consistently, in our results OVA encapsulated into Lp DPPC but not into Lp DPPG was efficiently uptaken by the B-1 cells. In addition, Lp DPPG had no influence on the PerC B-1-cell subset numbers or DPPC-specific antibody levels, suggesting the essential role of DPPC in stimulating these cells.
These findings, together with the observation that B-1 cells did not participate in the immune response induced by Lp DPPG/OVA, despite similar physicochemical characteristics of DPPC:Chol and DPPG:Chol liposomes, suggest an important role for phosphatidylcholine-specific B-1 cells in the immunostimulatory activity of DPPC liposomes. Interestingly, it has been shown that a phosphorylcholine-containing glycoprotein secreted by a filarial nematode was able to activate peritoneal B-1 cells (32) .
B-1 cells were involved in the enhancement of the antigen-specific antibody response induced by the liposomal preparation containing phosphatidylcholine. Although the mechanism for this immunostimulatory activity remains to be fully elucidated, the results obtained in this work point to two not mutually exclusive possibilities: (i) anti-DPPC IgMopsonized liposomes could be more efficiently internalized by antigen-presenting cells and (ii) B-1 cells themselves could be directly presenting antigens to T cells, which in turn would stimulate OVA-specific antibody production by B-2 cells.
Anti-liposomal DPPC IgM secretion by the B-1 cells increased upon stimulation with Lp DPPC/OVA in vitro and in vivo, confirming the fundamental role of these cells in the production of this specificity. Furthermore, in B-1-celldeficient animals immunized with Lp DPPC/OVA not only the anti-DPPC-specific IgM levels were affected but also the OVAspecific immune response, which points to the described role of B-1-cell-derived IgM in the enhancement of IgG production by B-2 cells (33, 34) . Liposomes could be opsonized by B-1-cell-produced IgM, resulting in more efficient uptake by antigen-presenting cells, thus enhancing the presentation of encapsulated antigens. In fact, IgM-opsonized particles are more efficiently internalized by macrophages (35) . B-1 cells are able to phagocytize parasites (36), apoptotic cells, latex or polystyrene particles and bacteria (37) (38) (39) (40) ; however, the uptake of liposomes has always been attributed to macrophages and dendritic cells (41) (42) (43) (44) . Similar phagocytic capabilities of B-1 cells and macrophages have been reported (38, 39) , and although in one study particle uptake was found not to be mediated by the BCR (40), in another one BCR specificity was important for this activity (45) . Additionally, B-1 cells exhibit phagocytic activity in lymphoid and myeloid form (36, 39, 40, 45) . Interestingly, at 4 h after liposome immunization of the BALB/xid mice adoptively transferred with B-1 cells stained with a non-specific dye, we detected a higher number of antigen-loaded cells by tracking 
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them through this dye than by using the specific CD19 marker, which suggested that a group of these cells had lost CD19 expression. At least in B-1b cells this process has been shown to occur in vitro, with the loss of B lymphocyte surface markers (IgM, CD19 and B220) (46, 47) . Therefore, the ability of the liposomal preparation to induce B-1-cell differentiation deserves further investigation.
In support of the possible role of B-1 cells as antigen-presenting cells, we have shown in vitro and in vivo that B-1 cells internalize more efficiently OVA encapsulated into liposomes and migrate to the spleen. The internalization of liposomes carrying OVA by these cells could stimulate the anti-OVA antibody response by presenting the antigen to CD4 + T cells. The function of B-1 cells as antigen-presenting cells has been widely recognized (45, 48, 49) . It was reported that B-1 cells from the PerC incorporating OVA adsorbed on latex beads activated OVA-specific CD4 + T cells (40) . In conclusion, we have demonstrated for the first time an important role of B-1 cells in the immunostimulatory properties of DPPC liposomes. Our data suggest that specificity of B-1 cells for phosphorylcholine is important for the adjuvant effect of DPPC liposomes. Further investigation will be addressed to elucidate the mechanisms behind the role of B-1 cells in the adjuvant properties of liposomes.
Supplementary data
Supplementary data are available at International Immunology Online. 
